Drug czar is an informal name for the person who directs drug-control policies in various areas. The term follows the informal use of the term czar in U.S. politics. The 'drug czar' title first appeared in a 1982 news story by United Press International that reported that, "[United States] Senators ... voted 62–34 to establish a 'drug czar' who would have overall responsibility for U.S. drug policy." [1] Since then, several ad hoc executive positions established in both the United States and United Kingdom have subsequently been referred to in this manner.
The Drug Commissioner of the German Federal Government has been called the nation's drug czar by the state media company Deutsche Welle. [2]
The first US Drug czar was Harry J. Anslinger who served as the first Commissioner of the Treasury Department's Federal Bureau of Narcotics from 1930 to 1962, under the administrations of five presidents: Hoover, Roosevelt, Truman, Eisenhower and Kennedy. Legislative efforts for marijuana prohibition under Anslinger included a push for all states to adopt similar drug laws, the Uniform State Narcotic Drug Act and the Marijuana Tax Act of 1937, which in effect criminalized the drug and set the stage for marijuana prohibition.
In California, the head of the state Bureau of Medical Cannabis has been called "marijuana czar". [5]
Following statewide medical and recreational legalization, the city of Sacramento, California appointed a director of cannabis policy and enforcement, called a pot czar. [6]
In Washington State, the consultant to the Washington State Liquor and Cannabis Board determining statewide procedures and regulations following legalization was "quickly dubbed 'pot czar'". [7] A similar cannabis regulation staff position in Oregon Liquor Control Commission was also called "marijuana czar". [8]
In the UK, Keith Hellawell, former Drugs Advisor to the Labour government of Tony Blair, has been referred to as a drug czar.
Harry Jacob Anslinger was an American government official who served as the first commissioner of the U.S. Treasury Department's Federal Bureau of Narcotics during the presidencies of Herbert Hoover, Franklin D. Roosevelt, Harry S. Truman, Dwight D. Eisenhower, and John F. Kennedy. He was a supporter of Prohibition, and of the criminalization of all drugs, and spearheaded anti-drug policy campaigns.
The Office of National Drug Control Policy (ONDCP) is a component of the Executive Office of the President of the United States.
John P. Walters is the president and chief executive officer of Hudson Institute; he was appointed in January 2021. He joined Hudson in 2009 as the executive vice president and most recently was the chief operating officer. Previously, Walters was Director of the White House Office of National Drug Control Policy (ONDCP) in the George W. Bush administration. He held that position from February 5, 2001 to January 20, 2009. As the U.S. "Drug Czar", Walters coordinated all aspects of federal anti-drug policies and spending. As drug czar, he was a staunch opponent of drug decriminalization, legalization, and medical marijuana.
The war on drugs is the policy of a global campaign, led by the United States federal government, of drug prohibition, military aid, and military intervention, with the aim of reducing the illegal drug trade in the United States. The initiative includes a set of drug policies that are intended to discourage the production, distribution, and consumption of psychoactive drugs that the participating governments, through United Nations treaties, have made illegal.
Commonly-cited arguments for and against the prohibition of drugs include the following:
In the United States, increased restrictions and labeling of cannabis as a poison began in many states from 1906 onward, and outright prohibitions began in the 1920s. By the mid-1930s cannabis was regulated as a drug in every state, including 35 states that adopted the Uniform State Narcotic Drug Act. The first national regulation was the Marihuana Tax Act of 1937.
The use, sale, and possession of cannabis containing over 0.3% THC by dry weight in the United States, despite laws in many states permitting it under various circumstances, is illegal under federal law. As a Schedule I drug under the federal Controlled Substances Act (CSA) of 1970, cannabis containing over 0.3% THC by dry weight is considered to have "no accepted medical use" and a high potential for abuse and physical or psychological dependence. Cannabis use is illegal for any reason, with the exception of FDA-approved research programs. However, individual states have enacted legislation permitting exemptions for various uses, including medical, industrial, and recreational use.
Cannabis in Oregon is legal for both medical and recreational use. In recent decades, the U.S. state of Oregon has had a number of legislative, legal, and cultural events surrounding use of cannabis. Oregon was the first state to decriminalize the possession of small amounts of cannabis, and among the first to authorize its use for medical purposes. An attempt to recriminalize possession of small amounts of cannabis was turned down by Oregon voters in 1997.
In the United States, the use of cannabis for medical purposes is legal in 38 states, four out of five permanently inhabited U.S. territories, and the District of Columbia, as of March 2023. Ten other states have more restrictive laws limiting THC content, for the purpose of allowing access to products that are rich in cannabidiol (CBD), a non-psychoactive component of cannabis. There is significant variation in medical cannabis laws from state to state, including how it is produced and distributed, how it can be consumed, and what medical conditions it can be used for.
This is a history of drug prohibition in the United States.
In the United States, cannabis is legal in 38 of 50 states for medical use and 24 states for recreational use. At the federal level, cannabis is classified as a Schedule I drug under the Controlled Substances Act, determined to have a high potential for abuse and no accepted medical use, prohibiting its use for any purpose. Despite this prohibition, federal law is generally not enforced against the possession, cultivation, or intrastate distribution of cannabis in states where such activity has been legalized. On May 1, 2024, the Associated Press reported on federal plans to change marijuana to a Schedule III drug.
Michael P. Botticelli is an American public health official who served as the director of the White House Office of National Drug Control Policy (ONDCP) from March 2014 until the end of President Obama's term. He was named acting director after the resignation of Gil Kerlikowske, and received confirmation from the United States Senate in February 2015. Prior to joining ONDCP, he worked in the Massachusetts Department of Public Health. Following completion of his service as ONDCP Director, he became the executive director of the Grayken Center for Addiction Medicine at the Boston Medical Center.
The legal history of cannabis in the United States began with state-level prohibition in the early 20th century, with the first major federal limitations occurring in 1937. Starting with Oregon in 1973, individual states began to liberalize cannabis laws through decriminalization. In 1996, California became the first state to legalize medical cannabis, sparking a trend that spread to a majority of states by 2016. In 2012, Washington and Colorado became the first states to legalize cannabis for recreational use.
Cannabis in Massachusetts is legal for medical and recreational use. It also relates to the legal and cultural events surrounding the use of cannabis. A century after becoming the first U.S. state to criminalize recreational cannabis, Massachusetts voters elected to legalize it in 2016.
Cannabis in Idaho is fully illegal for any use, whether recreational or medical. The laws on cannabis prohibition in Idaho are among the most severe in the United States, with possession of even small amounts of it a misdemeanor crime, and no legality of medical marijuana. As of 2018, support for the legalization of medical cannabis is broadly popular in the state, while legalization of the drug recreationally remains a wedge issue. Both the state's legislature as a whole and its governor, Brad Little, remain staunchly opposed to its legalization for medicinal or recreational purposes.
Cannabis in Washington relates to a number of legislative, legal, and cultural events surrounding the use of cannabis. On December 6, 2012, Washington became the first U.S. state to legalize recreational use of marijuana and the first to allow recreational marijuana sales, alongside Colorado. The state had previously legalized medical marijuana in 1998. Under state law, cannabis is legal for medical purposes and for any purpose by adults over 21.
Terms related to cannabis include:
The cannabis policy of the Reagan administration involved affirmation of the War on Drugs, government funded anti-cannabis media campaigns, expanded funding for law enforcement, involvement of the U.S. military in interdiction and eradication, reduction in emphasis in drug treatment, and creation of new Federal powers to test employees and seize cannabis-related assets.
We conclude that ONDCP's prepackaged news stories violate the ban on covert propaganda, but its use of the term "drug czar" to refer to ONDCP's Director does not violate the ban on self-aggrandizement.